Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-16-001598
Filing Date
2016-05-16
Accepted
2016-05-16 07:04:19
Documents
70
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2016-03-31 oxing10q.htm 10-Q 568807
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh311.htm EX-31.1 10363
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh312.htm EX-31.2 10496
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh321.htm EX-32.1 4828
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh322.htm EX-32.2 5104
  Complete submission text file 0001096906-16-001598.txt   2867125

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20160331.xml EX-101.INS 599961
7 XBRL TAXONOMY EXTENSION SCHEMA axn-20160331.xsd EX-101.SCH 33165
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axn-20160331_cal.xml EX-101.CAL 33474
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axn-20160331_def.xml EX-101.DEF 41879
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE axn-20160331_lab.xml EX-101.LAB 156563
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axn-20160331_pre.xml EX-101.PRE 142389
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 161650577
SIC: 2834 Pharmaceutical Preparations